Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-02-24

    Virtual Booth

    Contact Supplier

    Menu

    Obinutuzumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche’s Gazyva Shows Superiority in Lupus Nephritis in NEJM
    Roche’s Gazyva Shows Superiority in Lupus Nephritis in NEJM

    07 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/07/3022580/0/en/New-England-Journal-of-Medicine-publishes-new-data-for-Roche-s-Gazyva-Gazyvaro-which-shows-superiority-over-standard-therapy-in-people-with-active-lupus-nephritis.html

    GLOBENEWSWIRE
    07 Feb 2025
    Share Share
    Positive Ph 3 Results for Gazyva Show Superior to Std Therapy alone
    Positive Ph 3 Results for Gazyva Show Superior to Std Therapy alone

    26 Sep 2024

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20240925225486/en

    BUSSINESSWIRE
    26 Sep 2024
    Share Share
    AstraZeneca trumpets new Calquence combos in chronic lymphocytic leukaemia
    AstraZeneca trumpets new Calquence combos in chronic lymphocytic leukaemia

    30 Jul 2024

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2024/calquence-fixed-duration-combo-improved-1l-cll-pfs.html

    PRESS RELEASE
    30 Jul 2024
    Share Share
    US FDA approves expanded use of BeiGene's blood cancer drug
    US FDA approves expanded use of BeiGene's blood cancer drug

    08 Mar 2024

    // Mariam E Sunny REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-expanded-use-beigenes-blood-cancer-drug-2024-03-07/

    Mariam E Sunny REUTERS
    08 Mar 2024
    Share Share
    Nektar and Collaborators Present Data on NKTR-255 in Presentation
    Nektar and Collaborators Present Data on NKTR-255 in Presentation

    11 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nektar-and-collaborators-present-preclinical-data-on-nktr-255-combined-with-obinutuzumab-in-poster-presentation-at-the-65th-american-society-of-hematology-ash-annual-meeting-302011865.html

    PR NEWSWIRE
    11 Dec 2023
    Share Share
    Roche withdraws EMA expansion application for cancer medicine Gazyvaro
    Roche withdraws EMA expansion application for cancer medicine Gazyvaro

    21 Jul 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/roche-withdraws-ema-application-for-cancer-medicine-gazyvaros-new-indication/

    Katherine Lewin ENDPTS
    21 Jul 2023
    Share Share